Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer
Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer
Active, not recruiting · NCT04243616 · Registry updated 2026-07-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer | invasive breast carcinoma | Active, not recruiting | Phase 2 | 2026-07-27 | NCT04243616 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medical College of Wisconsin | 201 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Froedtert Hospital & Medical College of Wisconsin | Milwaukee | United States | 3 |